vs
Acadia Healthcare Company, Inc.（ACHC）与FIRST ADVANTAGE CORP（FA）财务数据对比。点击上方公司名可切换其他公司
Acadia Healthcare Company, Inc.的季度营收约是FIRST ADVANTAGE CORP的2.0倍（$821.5M vs $420.0M），FIRST ADVANTAGE CORP净利率更高（0.8% vs -143.3%，领先144.2%），FIRST ADVANTAGE CORP同比增速更快（36.8% vs 6.1%），FIRST ADVANTAGE CORP自由现金流更多（$62.2M vs $-179.5M），过去两年FIRST ADVANTAGE CORP的营收复合增速更高（57.5% vs 3.4%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
First Advantage是全球领先的劳动力筛查与背景验证服务提供商，服务覆盖科技、医疗、金融、零售、制造等多个行业的各规模客户，助力企业管控雇佣风险、满足合规要求，打造安全可信的工作环境。
ACHC vs FA — 直观对比
营收规模更大
ACHC
是对方的2.0倍
$420.0M
营收增速更快
FA
高出30.7%
6.1%
净利率更高
FA
高出144.2%
-143.3%
自由现金流更多
FA
多$241.6M
$-179.5M
两年增速更快
FA
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $821.5M | $420.0M |
| 净利润 | $-1.2B | $3.5M |
| 毛利率 | — | — |
| 营业利润率 | -142.4% | 10.7% |
| 净利率 | -143.3% | 0.8% |
| 营收同比 | 6.1% | 36.8% |
| 净利润同比 | -3710.4% | 103.5% |
| 每股收益（稀释后） | $-12.98 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCFA
| Q4 25 | $821.5M | $420.0M | ||
| Q3 25 | $851.6M | $409.2M | ||
| Q2 25 | $869.2M | $390.6M | ||
| Q1 25 | $770.5M | $354.6M | ||
| Q4 24 | $774.2M | $307.1M | ||
| Q3 24 | $815.6M | $199.1M | ||
| Q2 24 | $796.0M | $184.5M | ||
| Q1 24 | $768.1M | $169.4M |
净利润ACHCFA
| Q4 25 | $-1.2B | $3.5M | ||
| Q3 25 | $36.2M | $2.6M | ||
| Q2 25 | $30.1M | $308.0K | ||
| Q1 25 | $8.4M | $-41.2M | ||
| Q4 24 | $32.6M | $-100.4M | ||
| Q3 24 | $68.1M | $-8.9M | ||
| Q2 24 | $78.5M | $1.9M | ||
| Q1 24 | $76.4M | $-2.9M |
营业利润率ACHCFA
| Q4 25 | -142.4% | 10.7% | ||
| Q3 25 | 4.7% | 10.3% | ||
| Q2 25 | 5.8% | 9.7% | ||
| Q1 25 | 1.7% | 2.1% | ||
| Q4 24 | 4.9% | -26.3% | ||
| Q3 24 | 12.1% | 4.6% | ||
| Q2 24 | 13.4% | 5.4% | ||
| Q1 24 | 12.9% | -0.4% |
净利率ACHCFA
| Q4 25 | -143.3% | 0.8% | ||
| Q3 25 | 4.3% | 0.6% | ||
| Q2 25 | 3.5% | 0.1% | ||
| Q1 25 | 1.1% | -11.6% | ||
| Q4 24 | 4.2% | -32.7% | ||
| Q3 24 | 8.4% | -4.4% | ||
| Q2 24 | 9.9% | 1.0% | ||
| Q1 24 | 9.9% | -1.7% |
每股收益（稀释后）ACHCFA
| Q4 25 | $-12.98 | $0.03 | ||
| Q3 25 | $0.40 | $0.01 | ||
| Q2 25 | $0.33 | $0.00 | ||
| Q1 25 | $0.09 | $-0.24 | ||
| Q4 24 | $0.36 | $-0.67 | ||
| Q3 24 | $0.74 | $-0.06 | ||
| Q2 24 | $0.85 | $0.01 | ||
| Q1 24 | $0.83 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $133.2M | $240.0M |
| 总债务越低越好 | $2.5B | $2.1B |
| 股东权益账面价值 | $1.9B | $1.3B |
| 总资产 | $5.5B | $3.8B |
| 负债/权益比越低杠杆越低 | 1.28× | 1.61× |
8季度趋势，按日历期对齐
现金及短期投资ACHCFA
| Q4 25 | $133.2M | $240.0M | ||
| Q3 25 | $118.7M | $216.8M | ||
| Q2 25 | $131.4M | $184.3M | ||
| Q1 25 | $91.2M | $172.0M | ||
| Q4 24 | $76.3M | $168.7M | ||
| Q3 24 | $82.1M | $307.4M | ||
| Q2 24 | $77.2M | $269.6M | ||
| Q1 24 | $77.3M | $246.0M |
总债务ACHCFA
| Q4 25 | $2.5B | $2.1B | ||
| Q3 25 | $2.3B | $2.1B | ||
| Q2 25 | $2.3B | $2.1B | ||
| Q1 25 | $2.2B | $2.2B | ||
| Q4 24 | $2.0B | $2.2B | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.9B | — |
股东权益ACHCFA
| Q4 25 | $1.9B | $1.3B | ||
| Q3 25 | $3.1B | $1.3B | ||
| Q2 25 | $3.1B | $1.3B | ||
| Q1 25 | $3.0B | $1.3B | ||
| Q4 24 | $3.1B | $1.3B | ||
| Q3 24 | $3.0B | $920.7M | ||
| Q2 24 | $3.0B | $913.3M | ||
| Q1 24 | $2.9B | $907.7M |
总资产ACHCFA
| Q4 25 | $5.5B | $3.8B | ||
| Q3 25 | $6.4B | $3.9B | ||
| Q2 25 | $6.3B | $3.9B | ||
| Q1 25 | $6.1B | $3.9B | ||
| Q4 24 | $6.0B | $3.9B | ||
| Q3 24 | $5.9B | $1.7B | ||
| Q2 24 | $5.7B | $1.6B | ||
| Q1 24 | $5.5B | $1.6B |
负债/权益比ACHCFA
| Q4 25 | 1.28× | 1.61× | ||
| Q3 25 | 0.74× | 1.64× | ||
| Q2 25 | 0.74× | 1.65× | ||
| Q1 25 | 0.72× | 1.69× | ||
| Q4 24 | 0.64× | 1.66× | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.65× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-86.3M | $65.9M |
| 自由现金流经营现金流 - 资本支出 | $-179.5M | $62.2M |
| 自由现金流率自由现金流/营收 | -21.8% | 14.8% |
| 资本支出强度资本支出/营收 | 11.3% | 0.9% |
| 现金转化率经营现金流/净利润 | — | 19.01× |
| 过去12个月自由现金流最近4个季度 | $-439.9M | $188.5M |
8季度趋势，按日历期对齐
经营现金流ACHCFA
| Q4 25 | $-86.3M | $65.9M | ||
| Q3 25 | $73.2M | $72.4M | ||
| Q2 25 | $133.5M | $37.3M | ||
| Q1 25 | $11.5M | $19.5M | ||
| Q4 24 | $116.7M | $-85.7M | ||
| Q3 24 | $163.1M | $43.5M | ||
| Q2 24 | $171.1M | $32.0M | ||
| Q1 24 | $-321.3M | $38.3M |
自由现金流ACHCFA
| Q4 25 | $-179.5M | $62.2M | ||
| Q3 25 | $-63.0M | $71.2M | ||
| Q2 25 | $-34.2M | $36.1M | ||
| Q1 25 | $-163.2M | $19.0M | ||
| Q4 24 | $-86.8M | $-86.0M | ||
| Q3 24 | $-27.1M | $43.1M | ||
| Q2 24 | $16.9M | $31.4M | ||
| Q1 24 | $-463.7M | $38.0M |
自由现金流率ACHCFA
| Q4 25 | -21.8% | 14.8% | ||
| Q3 25 | -7.4% | 17.4% | ||
| Q2 25 | -3.9% | 9.2% | ||
| Q1 25 | -21.2% | 5.4% | ||
| Q4 24 | -11.2% | -28.0% | ||
| Q3 24 | -3.3% | 21.6% | ||
| Q2 24 | 2.1% | 17.0% | ||
| Q1 24 | -60.4% | 22.4% |
资本支出强度ACHCFA
| Q4 25 | 11.3% | 0.9% | ||
| Q3 25 | 16.0% | 0.3% | ||
| Q2 25 | 19.3% | 0.3% | ||
| Q1 25 | 22.7% | 0.1% | ||
| Q4 24 | 26.3% | 0.1% | ||
| Q3 24 | 23.3% | 0.2% | ||
| Q2 24 | 19.4% | 0.4% | ||
| Q1 24 | 18.5% | 0.2% |
现金转化率ACHCFA
| Q4 25 | — | 19.01× | ||
| Q3 25 | 2.02× | 27.91× | ||
| Q2 25 | 4.43× | 121.25× | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.18× | 17.22× | ||
| Q1 24 | -4.21× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
FA
| First Advantage Americas | $209.9M | 50% |
| Sterling | $185.9M | 44% |
| First Advantage International | $24.2M | 6% |
